Kate Haviland
Overview
Kate Haviland received an average of $2M in total compensation, including $346K in salary, at Blueprint Medicines between 2016 and 2017.
Source: SEC filing on April 27, 2018.
Related executives
We found ten more executives who work or worked at Blueprint Medicines.
Fouad Namouni
Blueprint Medicines
President, Research and Development
Jeffrey Albers
Blueprint Medicines
Chief Executive Officer
Kathryn Haviland
Blueprint Medicines
Chief Operating Officer
Tracey McCain
Blueprint Medicines
Chief Legal and Compliance Officer
Michael Landsittel
Blueprint Medicines
Chief Financial Officer
Anthony Boral
Blueprint Medicines
Chief Medical Officer
Christina Rossi
Blueprint Medicines
Chief Commercial Officer
Christopher Murray
Blueprint Medicines